News About: Pharm. Industry
Positive list system to restrict drug demand will hurt pharmaceutical sectorThe government is implementing its new drug pricing policy, the so-called positive list system, to exclude drugs of low quality from the insurance-covered drug lists, but this w...
|
Restructuring of domestic drug makers foreseeable
Influenced by a free trade accord between Korea and the United States and a new public health insurance regulation, the so-called positive list system, a number of Korean drug makers are likely to accelerate their res...
KFDA to restrict purchase of cold remedy
The Korea Food and Drug Administration announced on June 5 that customers will be unable to buy more than one or two boxes of cold medicine containing ephedrine (equivalent to 720 mg) at one time from a pharmacy.
...
Bayer, Schering Korea to be incorporated next year
Bayer HealthCare Korea and Schering Korea plan to integrate their business unit from January 1 next year.
The 2006 acquisition of Schering was the largest purchase in Bayer's history. The takeover led to the format...
Shinshin enjoying Liesend, a removal drug for hair lice .
According to a reliable industrial source on June 4, the sales of "Liesend Plus" of Shin Shin Pharmaceutical Inc. for the hair lice removal remedy, showed an explosive figure in the market.
A drug wholesaler said ...
FTA will hurt pharmaceutical sector
A local lawyer said Korea's pharmaceutical sector is expected to face an inevitable blow if a U.S.-Korea free trade agreement goes through.
The worst scenario is based upon the fact that the Korean government will ...
Diabetic drug markets in tumultuous turmoil.
A tremendous change seems to explode in the diabetic drug markets by the recent article on the cardiovascular disease risk of Avandia, an diabetic drug for the patients with type II diabetes, published in the New Engl...
SK Chemical launches lidocaine patch
SK Chemical said on May 31 it has launched Lidotop patch, which is a topical analgesic patch approved by the U.S. Food and Drug Administration (FDA) in 1999 to treat the pain associated with post-herpetic neuralgia (P...
Entertainment expenses of foreign drugmakers surpass 39 billion won
Leading foreign-invested pharmaceutical firms spent a total of 38.9 billion won in entertainment expenses last year, according to a recent report by the Financial Supervisory Service.
Entertainment expenses...
Pharmaceutical stock price index ever on rising.
Just in 2 days after the pharmaceutical stock price index reaching over the level of 4000, it showed break its record again by running over 4100, and on May 31 it being closed at 4108.79, 2.62% high from the previous ...
